Filing Flows › Immucell (ICCC) › Who owns the stock
Who owns Immucell (ICCC) stock
31 funds reported Immucell (ICCC) shares in their latest 13F filings, worth $15.2M in all. The largest holder is Vanguard Capital Management LLC ($2.7M). Last quarter 14 funds added to their stakes and 9 cut them.
Largest holders (13F)
| Fund | Shares | Value | Change | Quarter |
|---|---|---|---|---|
| Vanguard Capital Management LLC | 268,130 | $2.7M | increase | 2026-06-30 |
| Morgan Stanley | 233,910 | $2.4M | increase | 2026-06-30 |
| Vanguard Group | 302,996 | $1.9M | decrease | 2025-12-31 |
| Renaissance Technologies LLC | 171,089 | $1.7M | increase | 2026-06-30 |
| Cresset Asset Management, LLC | 135,267 | $1.4M | unchanged | 2026-06-30 |
| Geode Capital Management, LLC | 72,270 | $726K | increase | 2026-06-30 |
| Dimensional Fund Advisors LP | 58,452 | $587K | increase | 2026-06-30 |
| Bleichroeder LP | 50,000 | $502K | decrease | 2026-06-30 |
| Steadtrust LLC | 45,370 | $456K | decrease | 2026-06-30 |
| Mesirow Financial Investment Management | 42,481 | $427K | unchanged | 2026-06-30 |
| Citadel Advisors LLC | 40,503 | $407K | increase | 2026-06-30 |
| Vanguard Fiduciary Trust | 37,766 | $380K | decrease | 2026-06-30 |
| FAI Advisors | 26,868 | $263K | increase | 2026-09-30 |
| HighTower Advisors, LLC | 24,354 | $245K | unchanged | 2026-06-30 |
| BlackRock | 22,860 | $230K | increase | 2026-06-30 |
Immucell's latest quarter
Immucell, Q2 2026: revenue $7.2M (+12% year over year), operating margin 26.9%, net earnings $1.8M, operating cash flow $3.0M. The chart follows the revenue to costs, profit and cash.
Questions
Who owns the most ICCC stock?
By the latest 13F filings: Vanguard Capital Management LLC ($2.7M); Morgan Stanley ($2.4M); Vanguard Group ($1.9M); Renaissance Technologies LLC ($1.7M); Cresset Asset Management, LLC ($1.4M).
What is the short interest in ICCC?
18,103 shares were sold short at the 2026-10-15 settlement, -18.13% of the float.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.